Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment
Authors
Keywords
-
Journal
JAMA Network Open
Volume 5, Issue 1, Pages e2145319
Publisher
American Medical Association (AMA)
Online
2022-01-29
DOI
10.1001/jamanetworkopen.2021.45319
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease
- (2020) Charles E. Evans et al. ACTA NEUROPATHOLOGICA
- Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
- (2020) Gill Livingston et al. LANCET
- Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment
- (2020) Ihab Hajjar et al. JAMA Network Open
- Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report
- (2020) Calvin L. Colvin et al. JAMA Network Open
- Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia
- (2019) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Divergence in the activity of the N- and C- catalytic domains of ACE1 - implications for the role of the renin-angiotensin system in Alzheimer’s disease
- (2019) Noura S. AL Mulhim et al. Acta Neuropathologica Communications
- Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years
- (2018) Nicholas I. Bradfield et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress Toward Disease Prevention and Treatment?
- (2018) Patrick Gavin Kehoe JOURNAL OF ALZHEIMERS DISEASE
- Cognitive benefits of angiotensin IV and angiotensin-(1–7): A systematic review of experimental studies
- (2018) Jean K. Ho et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
- (2018) Steven J. Forrester et al. PHYSIOLOGICAL REVIEWS
- Neurovascular and Cognitive failure in Alzheimer’s Disease: Benefits of Cardiovascular Therapy
- (2016) Edith Hamel et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Prognostic Significance of Mild Cognitive Impairment Subtypes for Dementia and Mortality: Data from the NEDICES Cohort
- (2016) Félix Bermejo-Pareja et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer’s Disease
- (2015) Robert Baranello et al. Current Alzheimer Research
- A Randomized Trial of Intensive versus Standard Blood-Pressure Control
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Association Between Angiotensin Receptor Blockers and Longitudinal Decline in Tau in Mild Cognitive Impairment
- (2015) Ihab Hajjar et al. JAMA Neurology
- The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT)
- (2014) Walter T Ambrosius et al. Clinical Trials
- Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease
- (2014) Parunyou Julayanont et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Single-Domain Amnestic Mild Cognitive Impairment Identified by Cluster Analysis Predicts Alzheimer's Disease in the European Prospective DESCRIPA Study
- (2013) Marinella Damian et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- A Weighting Analogue to Pair Matching in Propensity Score Analysis
- (2013) Liang Li et al.
- Impact of Angiotensin Receptor Blockers on Alzheimer Disease Neuropathology in a Large Brain Autopsy Series
- (2012) Ihab Hajjar et al. ARCHIVES OF NEUROLOGY
- Memory Impairment, in Mild Cognitive Impairment without Significant Cerebrovascular Disease, Predicts Progression to Alzheimer’s Disease
- (2012) Young Min Lee et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- The validity of amnestic MCI and non-amnestic MCI at age 75 in the prediction of Alzheimer's dementia and vascular dementia
- (2012) S. Jungwirth et al. INTERNATIONAL PSYCHOGERIATRICS
- Neuropsychological measures predict decline to Alzheimer's dementia from mild cognitive impairment.
- (2012) Mathew J. Summers et al. NEUROPSYCHOLOGY
- Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage
- (2010) Masatsugu Horiuchi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Negative Controls
- (2010) Marc Lipsitch et al. EPIDEMIOLOGY
- Diagnostic transitions in mild cognitive impairment subtypes
- (2009) Orestes Vicente Forlenza et al. INTERNATIONAL PSYCHOGERIATRICS
- Two-year outcome of MCI subtypes and aetiologies in the Goteborg MCI study
- (2009) A. Nordlund et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Attenuation of Focal Brain Ischemia by Telmisartan, an Angiotensin II Type 1 Receptor Blocker, in Atherosclerotic Apolipoprotein E-Deficient Mice
- (2008) Masaru IWAI et al. HYPERTENSION RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started